- Home
- A-Z Publications
- Current Drug Metabolism
- Previous Issues
- Volume 2, Issue 1, 2001
Current Drug Metabolism - Volume 2, Issue 1, 2001
Volume 2, Issue 1, 2001
-
-
Multiple Oxidants in Cytochrome P450 Catalyzed Reactions Implications for Drug Metabolism
By A.D.N. VazThe activation of molecular oxygen by Cytochromes P450 to the ultimate mono-oxygen oxidant species involves three distinct dioxygen species coordinated to the heme iron. These intermediates have different chemical properties, and have recently been proposed to participate in some Cytochrome P450- catalyzed oxidation reactions. This article reviews the extent of our current knowledge on the roles proposed for the Read More
-
-
-
Enzyme Kinetics of Cytochrome P450-Mediated Reactions
Authors: M. Shou, Y. Lin, P. Lu, C. Tang, Q. Mei, D. Cui, W. Tang, J.S. Ngui, C.C. Lin, R. Singh, B.K. Wong, J.A. Yergey, J.H. Lin, P.G. Pearson, T.A. Baillie, A.D. Rodrigues and T.H. RushmoreThe most common drug-drug interactions may be understood in terms of alterations of metabolism, associated primarily with changes in the activity of cytochrome P450 (CYP) enzymes. Kinetic parameters such as K m , V max , K i and K a , which describe metabolism-based drug interactions, are usually determined by appropriate kinetic models and may be used to predict the pharmacokinetic consequences of ex Read More
-
-
-
Pharmacology of Chiral Compounds 2-Arylpropionic Acid Derivatives
Authors: M.F. Landoni and A. SoraciMolecules exist as three dimensional structures. Therefore they can exist in symmetrical and asymmetrical forms. Molecules with an asymmetric centre are chiral. If the molecule and its mirror image are non-superimposable, the relationship between the two molecules is enantiomeric and the two stereoisomers are enantiomers. Since enantiomers have very similar or identical physicochemical properties, it is very difficult t Read More
-
-
-
Pharmacodynamics of High-Dose Chemotherapy
By Y. NetioThere is usually considerable variability in anticancer drug plasma levels when delivered at high doses requiring stem-cell support. Given their narrow therapeutic windows and wide interpatient pharmacokinetic variability, drug monitoring and pharmacokinetic-directed dosing represent an attractive strategy in this setting. A major previous requirement to successful application of therapeutic drug monitoring is identification Read More
-
-
-
Bestatin as an Experimental Tool in Mammals
Authors: O.A. Scornik and V. BotbolBestatin, an antibiotic of microbial origin, is a potent inhibitor of some, but not all aminopeptidases. It can be administered, with low toxicity, to cultured cells, intact animals and humans. It has become a useful tool in elucidating the physiological role of some mammalian exopeptidases in the regulation of the immune system, in the growth of tumors and their invasion of surrounding tissues, and in the degradation of cellula Read More
-
Volumes & issues
-
Volume 25 (2024)
-
Volume 24 (2023)
-
Volume 23 (2022)
-
Volume 22 (2021)
-
Volume 21 (2020)
-
Volume 20 (2019)
-
Volume 19 (2018)
-
Volume 18 (2017)
-
Volume 17 (2016)
-
Volume 16 (2015)
-
Volume 15 (2014)
-
Volume 14 (2013)
-
Volume 13 (2012)
-
Volume 12 (2011)
-
Volume 11 (2010)
-
Volume 10 (2009)
-
Volume 9 (2008)
-
Volume 8 (2007)
-
Volume 7 (2006)
-
Volume 6 (2005)
-
Volume 5 (2004)
-
Volume 4 (2003)
-
Volume 3 (2002)
-
Volume 2 (2001)
-
Volume 1 (2000)
Most Read This Month
Article
content/journals/cdm
Journal
10
5
false
en
